This document discusses pharmaceutical suspensions. It begins by defining a suspension as a coarse dispersion containing finely divided insoluble material suspended in a liquid medium. Suspensions are classified as either dilute or concentrated based on the proportion of solid, and as flocculated or deflocculated based on particle behavior. Flocculated suspensions have particles that form loose aggregates (flocs) while deflocculated suspensions have individually dispersed particles. The document outlines factors that influence particle settling such as size, shape, density, and viscosity. It provides quantitative expressions for sedimentation volume and degree of flocculation. Finally, it discusses formulation considerations for suspensions and methods for controlled flocculation using electrolytes or polymers.
Introduction
Definition
Features desired in pharmaceutical suspension
Advantage/Disadvantages of pharmaceutical suspension
Flocculated and deflocculated suspension
Interfacial properties of suspending particles
Settling in suspensions
Effect of Brownian movement,
Sedimentation of flocculated particles,
Sedimentation parameters
Formulation of suspensions
Wetting of Particles,
Controlled flocculation,
Flocculation in structured vehicle
Introduction
Definition
Features desired in pharmaceutical suspension
Advantage/Disadvantages of pharmaceutical suspension
Flocculated and deflocculated suspension
Interfacial properties of suspending particles
Settling in suspensions
Effect of Brownian movement,
Sedimentation of flocculated particles,
Sedimentation parameters
Formulation of suspensions
Wetting of Particles,
Controlled flocculation,
Flocculation in structured vehicle
Dispersion system
suspensions
interfacial properties of suspensions
zeta potential
Sedimentation parameters
Settling in suspension
Formulation of suspension
Preparation of suspension
Suspension is made of two phase system, consisting of a finely divided solid particles (Dispersed phase) distributed in a particular manner throughout another medium (Continuous phase).
A pharmaceutical suspension is a heterogeneous system in which finely divided solid particles are dispersed in a liquid medium. Unlike solutions, where solutes are completely dissolved, suspensions involve particles that are only partially soluble or insoluble in the liquid. These suspensions are commonly used in the pharmaceutical industry to deliver medications that may be poorly soluble or unstable in their pure form. The solid particles, often in the form of powders or crystals, are dispersed throughout the liquid phase, creating a stable mixture through the use of suspending agents or stabilizers. These agents prevent the settling of particles, ensuring uniform distribution and ease of redispersion upon shaking before administration. Pharmaceutical suspensions offer advantages in terms of flexibility in dosing and formulation, enabling the delivery of therapeutic agents in various forms such as oral liquids, injectables, or topical preparations, enhancing patient compliance and therapeutic efficacy. The formulation and stability of pharmaceutical suspensions require careful consideration of factors such as particle size, density, and the choice of stabilizers to maintain a consistent and reliable product.
Pharmaceutical Suspension Dosage Form (PPT)Prachi Pandey
A pharmaceutical suspension is a heterogeneous system in which finely divided solid particles are dispersed in a liquid medium. Unlike solutions, where solutes are completely dissolved, suspensions involve particles that are only partially soluble or insoluble in the liquid. These suspensions are commonly used in the pharmaceutical industry to deliver medications that may be poorly soluble or unstable in their pure form. The solid particles, often in the form of powders or crystals, are dispersed throughout the liquid phase, creating a stable mixture through the use of suspending agents or stabilizers. These agents prevent the settling of particles, ensuring uniform distribution and ease of redispersion upon shaking before administration. Pharmaceutical suspensions offer advantages in terms of flexibility in dosing and formulation, enabling the delivery of therapeutic agents in various forms such as oral liquids, injectables, or topical preparations, enhancing patient compliance and therapeutic efficacy. The formulation and stability of pharmaceutical suspensions require careful consideration of factors such as particle size, density, and the choice of stabilizers to maintain a consistent and reliable product.
Suspension are biphasic liquids dosage form in which insoluble solid particulate are uniformly distributed in liquid phase which may be stabilized by inclusion of suspending agents.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Dispersion system
suspensions
interfacial properties of suspensions
zeta potential
Sedimentation parameters
Settling in suspension
Formulation of suspension
Preparation of suspension
Suspension is made of two phase system, consisting of a finely divided solid particles (Dispersed phase) distributed in a particular manner throughout another medium (Continuous phase).
A pharmaceutical suspension is a heterogeneous system in which finely divided solid particles are dispersed in a liquid medium. Unlike solutions, where solutes are completely dissolved, suspensions involve particles that are only partially soluble or insoluble in the liquid. These suspensions are commonly used in the pharmaceutical industry to deliver medications that may be poorly soluble or unstable in their pure form. The solid particles, often in the form of powders or crystals, are dispersed throughout the liquid phase, creating a stable mixture through the use of suspending agents or stabilizers. These agents prevent the settling of particles, ensuring uniform distribution and ease of redispersion upon shaking before administration. Pharmaceutical suspensions offer advantages in terms of flexibility in dosing and formulation, enabling the delivery of therapeutic agents in various forms such as oral liquids, injectables, or topical preparations, enhancing patient compliance and therapeutic efficacy. The formulation and stability of pharmaceutical suspensions require careful consideration of factors such as particle size, density, and the choice of stabilizers to maintain a consistent and reliable product.
Pharmaceutical Suspension Dosage Form (PPT)Prachi Pandey
A pharmaceutical suspension is a heterogeneous system in which finely divided solid particles are dispersed in a liquid medium. Unlike solutions, where solutes are completely dissolved, suspensions involve particles that are only partially soluble or insoluble in the liquid. These suspensions are commonly used in the pharmaceutical industry to deliver medications that may be poorly soluble or unstable in their pure form. The solid particles, often in the form of powders or crystals, are dispersed throughout the liquid phase, creating a stable mixture through the use of suspending agents or stabilizers. These agents prevent the settling of particles, ensuring uniform distribution and ease of redispersion upon shaking before administration. Pharmaceutical suspensions offer advantages in terms of flexibility in dosing and formulation, enabling the delivery of therapeutic agents in various forms such as oral liquids, injectables, or topical preparations, enhancing patient compliance and therapeutic efficacy. The formulation and stability of pharmaceutical suspensions require careful consideration of factors such as particle size, density, and the choice of stabilizers to maintain a consistent and reliable product.
Suspension are biphasic liquids dosage form in which insoluble solid particulate are uniformly distributed in liquid phase which may be stabilized by inclusion of suspending agents.
Similar to coarse-dispersions-suspension.pptx (20)
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
1. Presented by: Miss Arti Darode
(Asst. Professor)
Nagpur College of Pharmacy
Coarse dispersion, suspensions
1
2. Outlines
2
• Introduction
• Classifications
• Interfacial Properties
• Factor s influencing particle settling.
• Quantitative expression of sedimentation
and flocculation
• Formulation of suspension
• Controlled flocculation
3. Introduction
• A pharmaceutical suspension may be defined as a coarse dispersion containing finely
divided insoluble material suspended in a liquid medium.
• In this preparations, the substance distributed is referred to as the dispersed phase
(solid particles), and the vehicle is termed as continuous phase or dispersion
medium.
• Coarse dispersion 10 to 50 μm
• Fine dispersions 0.5 to 10 μm
• Particles ˂ 5 µm show Brownian movement
• They could be
• Oral suspension
3
4. Introduction cont.
Why suspensions?
• Applications:
• Stability : Certain drugs are chemically unstable in solution but stable when
suspended.
• Easy to administered :Ease of swallowing liquids
• To mask the taste of bitter drug: The disadvantage of a disagreeable taste of
certain drugs in solution form is overcome.
• Prolong effect : Suspensions offer a way to provide sustained release effect.
• Bioavilability: Higher rate of Bioavilability as compare to other.
4
5. Desirable Properties of Suspensions
2. No rapid settling of
suspended particles
3.If the particles do settle,
they must not form a hard
cake at the bottom of the
container & should be easily
re-dispersible into uniform
mixture when shaken.
4.suspension should
be easily pourable.
5.Parenteral preparations: it
should flow through the
syringe needle.
6.External preparations:
spread easily on the
surface of the skin &
imust not be too fluid to
run off the skin surface
1.The color & odor should be
acceptable and pleasing for
oral & external uses.
5
6. Introduction cont….
• Sediment of solid gives false alarm of suitability of drug
• Dose precision can’t achieve (potent drug should not give)
• Physical stability ,sedimentation ,& compaction causes problem
• Liable to undergo oxidation & hydrolysis
Limitations / Disadvantages
6
7. Outlines
7
• Introduction
• Classifications
• Interfacial Properties
• Factor s influencing particle settling.
• Quantitative expression of sedimentation
and flocculation
• Formulation of suspension
• Controlled flocculation
8. Classification
8
• Based on proportion of solid ,suspension is classified as dilute or concentrated
• Concentrated suspension contains 50%w/v solid
• Dilute suspension contains 2-10 %w/v solid
• Depending on nature & behavior of solids suspension is classified as
flocculated & deflocculated suspension
9. Flocculation and Deflocculation in suspensions
The overall (or resultant) charge existing on the
suspended particle is called as zeta potential and
it is a measurable indication of the charge.
Therefore, flocculation and deflocculation
may be considered in terms of zeta potential.
When the zeta potential is high, the particles
remain dispersed and are said to be
deflocculated.
These particles resist collision due to the high
zeta potential even if the particles are
brought close by way of random motion or
agitation.
9
10. The zeta potential can be progressively lowered by the
addition of an electrolyte (whose ion which is oppositely
charged to that of the suspended particles is preferentially
adsorbed).
At some concentration of the electrolyte, the forces of
attraction dominate over the electrical forces of repulsion
slightly.
Under these conditions (i.e. when the zeta potential is
sufficiently lowered), the particles when they approach each
other, form loose aggregates commonly called flocs.
Then such a suspension is said to be flocculated.*
10
Flocculation
12. Flocculated Suspension Deflocculated Suspension
• Particles form light fluffy conglomerates called The particles in the suspension remain
flocs. individually.
• Since the flocs are groups of particles, rate of
sedimentation is fast.
Since the particles are small and remain
separately, the rate of sedimentation is slow.
• Formation of sediment is
quick.
Formation of sediment at the bottom of the
container takes a long time.
• The sediment is loosely packed and presents a
scaffold like structure with entrapped liquid. The
sediment does not form a dense hard cake.
The sediment formed becomes eventually a
hard cake.
• Sediment volume is high. Sediment volume is small.
• The supernatant liquid becomes clear at a
shorter time since small particles are entrapped
within the floes and settle along with floes
rapidly.
The supernatant liquid remains cloudy for a longer
time as very small particles approaching colloidal
dimensions) take very long time to settle.
• Redistribution of the sedimented particles by Redistribution of the sedimented particles by
shaking the container is easy. shaking the container is difficult.
12
13. Fig. 17-1. Potential energy curves for particle interactions in suspension. (From A. Martin, J. Pharm.
Sci. 50, 514, 1961. With permission.)
PARTICLE - PARTICLE INTRACTION & BEHAVIOUR
13
14. Outlines
14
• Introduction
• Classifications
• Interfacial properties of solid
• Factor s influencing particle settling
• Quantitative expression of sedimentation and flocculation
• Formulation of suspension
• Controlled flocculation
15. Interfacial Properties
Two factors must be taken into account, when the interfacial properties
between the solid phase and the liquid are considered:
• Surface free energy increase resulting from increase in surface area of suspended particles
due to reduction in size of particles
• Presence of electrical charges on the surface of the dispersed solid particles in a liquid
medium.
The increase in surface free energy due to a reduction in size of the particles
is given by the relation: ∆G = γ ∆’A ----------------------- (1)
Where ∆G = increase in surface free energy in ergs, ∆A = increase in surface area in cm2,
γ = interfacial tension in dynes/cm.
15
16. Outlines
16
• Introduction
• Reasons for suspension
• Features desired in pharmaceutical suspension
• Classifications
• Interfacial properties of solid
• Factor s influencing particle settling
• Quantitative expression of sedimentation and flocculation
• Formulation of suspension
• Controlled flocculation
18. • Brownian movement
When the size of the dispersed particles approach that of
colloidal dimensions, Brownian motion sets in. Such a
Brownian motion may be observed if the size of the
particle is reduced approximately to 2µ.
However the Brownian movement depends on the density
of the particles and the density and viscosity of the
dispersion medium.
Considering the size of the particles normally found in
most of the pharmaceutical suspensions it is unlikely that
the particles will undergo Brownian movement.
18
20. Stoke’s law is applicable to dilute suspensions containing
spherical particles and the settling of particles should be slow with
less turbulence i.e. the settling should be streamline.
Pharmaceutical suspensions being concentrated, there is
disturbance for the settling of particles and hence Stoke’s law
cannot be effectively applied.
However, these factors may be expected to influence the rate of
settling.
According to Stoke’s law, settling rate for the particles may be
reduced by decreasing the particle size provided the particles are
deflocculated.
20
21. Size of particle:
• Particle size reduce half of its original size, the rate of sedimentation decreases
• Reducing particle size to extreme aggregation will occur due to increase in surface free
energy
• Further fine particle have tendency to form compact cake on storage.
• Settling of particle require plenty of time to pack tightly by falling one another to form
cake.
Density of medium
• Density of solid generally 1.5-2g/cm3
• a/c to equation if density of medium is equal to density of solid so rate of sedimentation will
zero
• Therefore there is need to increase in density of medium so difference in density will
minimize
• Density can increase by adding verious thickning agent like PVP , PVC, Sugars, Glycerin
21
22. The rate of sedimentation may be delayed by increasing the viscosity of the medium (by
adding suitable suspending agents) as it is inversely related to the viscosity of the dispersion
medium.
This approach to reduce the rate of sedimentation is frequently used. However there
is an optimum level for this approach as too much increase in viscosity may hinder the
flow of the suspension out of the container.
That is, pourability is affected and the viscosity increase may also make the
redistribution of the particles uniformly throughout the dispersion medium difficult.
The other approach that may be applied is to narrow down the density difference
between the dispersed particles and the dispersion medium.
This is seldom possible as the density of solid particles is always greater than the liquid.
Viscosity
22
24. Quantitative expressions of sedimentation and flocculation {physical stability}
Sedimentation Volume F The sedimentation volume, F, is the ratio of the equilibrium
volume of the sediment, Vu, to the total volume of the suspension, V0.
• F = Vu / V0
• F is normally ranges from nearly 0 to 1.
• When F = 1,
• No sediment is apparent even though the system is flocculated.
• Caking also will be absent.
• The suspension is esthetically pleasing, there being no visible,
clear supernatant
24
25. Quantitative expressions of sedimentation and flocculation
Degree of flocculation β
• β =
𝐹𝑓𝑙𝑜𝑐
25
𝐹𝑑𝑒𝑓𝑙𝑜𝑐
• Is a parameter for comparing flocculated systems
26. What have you learnt?
• What are pharmaceutical suspensions? What are the roles of suspensions as a dosage
form?
• Classify of suspensions
• What are the differences between flocculated and deflocculated suspensions?
• What is the degree of flocculation?
26
27. Effect of viscosity
27
• The traditional approach was to raise the viscosity of the dispersion medium to the
point at which sedimentation is very low.
• It would be difficult to remove a dose from the container
• It decreased the rate of sedimentation, but it is impossible to halt
sedimentation.
• Difficult to redisperse the sediment.
28. Outlines
28
• Introduction
• Reasons for suspension
• Features desired in pharmaceutical suspension
• Classifications
• Physical features of the dispersed phase
• Flocculation and deflocculation
• Quantitative expression of sedimentation and flocculation
• Formulation of suspension
• Controlled flocculation
29. Formulation of suspension
• Like alcohol , glycerin, SLS
and Tween
• Minimum amount should
be used
• They are aqueous solution
of polymer
• Usually negatively charged
in aqueous media
• E.g MC, CMC, bentonite
and carbomer
• Non-Newtonian materials
of this type are preferred
over Newtonian
4/17/2017 Pharmaceutical Compounding, Dr. rer. nat. Rebaz Ali 29
30. Outlines
4/17/2017 Pharmaceutical Compounding, Dr. rer. nat. Rebaz Ali 30
• Introduction
• Reasons for suspension
• Features desired in pharmaceutical suspension
• Classifications
• Physical features of the dispersed phase
• Flocculation and deflocculation
• Quantitative expression of sedimentation and flocculation
• Formulation of suspension
• Controlled flocculation
31. Controlled flocculation
1. Electrolytes
• They are the most widely used flocculating agents.
• They act by reducing the electrical forces
of repulsion between particles, thereby
allowing the particles to form the loose
flocs.
• Example like addition of AlCl3 into
sulfamerazine in water which has negative
charge.
4/17/2017 Pharmaceutical Compounding, Dr. rer. nat. Rebaz Ali 31
32. Controlled flocculation cont.
2. Polymers
• Many polymers contain polar
functional groups that are separated
by a hydrocarbon backbone.
• A polymer molecule may adsorb to
particle surfaces while maintaining a
degree of interaction with the
solvent.
4/17/2017 Pharmaceutical Compounding, Dr. rer. nat. Rebaz Ali 32